The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
JHFH,
Respectfully I'm not sure I agree.
Vlad was condemned on here for not communicating. Now you are saying he shouldn't share what he knows. The less he tells us the more nervy genuine LTH become. It creates a vacuum for Stu and others to fill - can't you imagine Stu posting that the lack of clarity means the CH is a serious problem? As an aside when I worked in IR we had a rule of no surprises, neither good nor bad, be clear, get a name for consistently delivering on your word and that was the route to least price manipulation/swings. We used to joke about being boringly predictable.
I also think the website is neither here nor there. Which serious investor starts their investment search with google then judges the merit of the pipeline on the website?
I was very disappointed with the Ind news. I was underwater before and am considerably more so now. Hemo is my largest investment and this hurts.
I am struggling with the level of acrimony though. Blaming vlad is pointless- without him there isn’t any hemo so we have to take the bits we don’t like as graciously as the bits we do. We can’t have the 50% of him we like but not the other 50%.
Finally what do people expect? We’ve invested in a tiny company trying (among other things) to try and cure a particularly tricky cancer - did we really expect a smooth ride? You don’t get a shot at huge rewards with a sure thing.
I have the upmost respect for you JHFH but in the spirit of Saints note would point out HL reckon the marker therapeutics market cap is $13m not $74m. I would also add that for Hemos shareprice to increase money needs to flow in, if no new money flows in .... so 2 companies can have 2 v different valuations for no other reason than one was last to 'the party'